Current guidelines that advocate the avoidance of NSAIDs and use of small chest tubes in patients with malignant pleural effusion undergoing pleurodesis have been challenged by a group of international experts. Writing in JAMA the research team including Professor Y.C. Gary Lee from Sir Charles Gairdner Hospital in Perth, Western Australia explained that clinicians traditionally avoided NSAIDs ...
Already a member?
Enter your email to keep reading.